Cited by 163Immune cells in cancerImmunotherapy and Immune ResponsesPhagocytosis and Immune Regulation

Targeting macrophages rescues age‐related immune deficiencies in C57 BL/6J geriatric mice

Open access
Jackaman, Connie, Radley‐Crabb, Hannah G., Soffe, Zoe, Shavlakadze, Tea, Grounds, Miranda D., Nelson, Delia J.·2013·Aging Cell

Abstract

Changes to innate cells, such as macrophages and myeloid-derived suppressor cells (MDSCs), during aging in healthy or tumor-bearing hosts are not well understood. We compared macrophage subpopulations and MDSCs from healthy young (6-8 weeks) C57BL/6J mice to those from healthy geriatric (24-28 months) mice. Spleens, lymph nodes, and bone marrow of geriatric hosts contained significantly more M2 macrophages and MDSCs than their younger counterparts. Peritoneal macrophages from geriatric, but not young, mice co-expressed CD40 and CX3CR1 that are usually mutually exclusively expressed by M1 or M2 macrophages. Nonetheless, macrophages from geriatric mice responded to M1 or M2 stimuli similarly to macrophages from young mice, although they secreted higher levels of TGF-β in response to IL-4. We mimicked conditions that may occur within tumors by exposing macrophages from young vs. geriatric mice to mesothelioma or lung carcinoma tumor cell-derived supernatants. While both supernatants skewed macrophages toward the M2-phenotype regardless of age, only geriatric-derived macrophages produced IL-4, suggesting a more immunosuppressive tumor microenvironment will be established in the elderly. Both geriatric- and young-derived macrophages induced allogeneic T-cell proliferation, regardless of the stimuli used, including tumor supernatant. However, only macrophages from young mice induced T-cell IFN-γ production. We examined the potential of an IL-2/agonist anti-CD40 antibody immunotherapy that eradicates large tumors in young hosts to activate macrophages from geriatric mice. IL-2-/CD40-activated macrophages rescued T-cell production of IFN-γ in geriatric mice. Therefore, targeting macrophages with IL-2/anti-CD40 antibody may improve innate and T-cell immunity in aging hosts.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/acel.12062

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Geriatric mice aged 24-28 months have more macrophages in spleen and bone marrow than young mice.

    “Geriatric mice (24-28 months old) have elevated numbers of macrophages in the spleen and bone marrow as compared to young mice (57).”

    From The impact of ageing on monocytes and macrophages (2021) · cites this paper as [57]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jackaman, C., Radley‐Crabb, H. G., Soffe, Z., Shavlakadze, T., Grounds, M. D., & Nelson, D. J.
Affiliations
  • Curtin University (AU)
  • The University of Western Australia (AU)
Corresponding author
Jackaman, Connie
Venue
Aging Cell
Publisher
Wiley
Published
2013-03-27
Volume
12
Issue
3
Pages
345-357
ISSN
  • 1474-9718 (ISSN-L)
  • 1474-9726
OpenAlex
W2097861054
Cited by
162
References
45
Citations by year
2026: 6 · 2025: 15 · 2024: 19 · 2023: 14 · 2022: 20 · 2021: 15 · 2020: 11 · 2019: 13 · 2018: 8 · 2017: 14 · 2016: 11 · 2015: 7 · 2014: 4 · 2013: 5
FWCI
4.97
Type
journal article
Language
en
Open access
Locations
  • Aging Cell (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • eSpace (Curtin University) (submittedVersion)
Funders
  • Australian Government
  • Curtin University of Technology
  • Cancer Council Western Australia
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
Keywords
macrophages, myeloid-derived suppressor cells, aging, M2 macrophages, CD40, CX3CR1, TGF-beta, IL-4, tumor microenvironment, mesothelioma, lung cancer, allogeneic T cell proliferation, interferon-gamma, anti-CD40 antibody, interleukin-2, immunotherapy
MeSH terms
CX3C Chemokine Receptor 1, Aging, Animals, Immunity, Innate, Interferon-gamma, Interleukin-2, Lung Neoplasms, Lymphocyte Activation, Macrophages, Mesothelioma, Mice, Inbred C57BL, CD4-Positive T-Lymphocytes, Interleukin-4, Transforming Growth Factor beta, Cellular Senescence, Culture Media, Conditioned, CD8-Positive T-Lymphocytes, CD40 Antigens, Receptors, Chemokine, Cell Line, Tumor, Cell Proliferation, Mice, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review